2010
DOI: 10.1093/rheumatology/kep470
|View full text |Cite
|
Sign up to set email alerts
|

Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases

Abstract: Our results demonstrate that the coding variant rs763361 in CD226 gene is associated with multiple ADs in non-European populations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
58
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(60 citation statements)
references
References 40 publications
1
58
1
Order By: Relevance
“…In previous studies, the rs763361 SNP in the CD226 gene has been reported to be associated with susceptibility to autoimmune diseases Douroudis et al, 2010;Maiti et al, 2010), including T1D in a Brazilian population (Mattana et al, 2014). Moreover, Lofgren et al (2010) identified the potential interference of the rs727088 SNP on the regulation of CD226 transcription both in T cells and natural killer cells.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…In previous studies, the rs763361 SNP in the CD226 gene has been reported to be associated with susceptibility to autoimmune diseases Douroudis et al, 2010;Maiti et al, 2010), including T1D in a Brazilian population (Mattana et al, 2014). Moreover, Lofgren et al (2010) identified the potential interference of the rs727088 SNP on the regulation of CD226 transcription both in T cells and natural killer cells.…”
Section: Discussionmentioning
confidence: 94%
“…Recently, several SNPs in the CD226 gene, such as rs763361 and rs727088, have been reportedly associated with several autoimmune diseases, including rheumatoid arthritis, systemic sclerosis, Graves' disease, systemic lupus erythematosus (SLE), and multiple sclerosis Douroudis et al, 2009;Maiti et al, 2010). The association of the rs763361 or rs727088 SNPs with T1D risk was also investigated in several studies.…”
Section: Introductionmentioning
confidence: 99%
“…Four articles were excluded because 2 were review articles, 1 contained duplicate data, and 1 had no data concerning the polymorphisms. Thus, 19 studies met our inclusion criteria [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31]. They consisted of 8 studies on the CTLA-4 polymorphism with 2093 patients and 2480 controls, 5 on the CD226 polymorphism with 2278 patients and 1940 controls, 6 on the FAS polymorphism with 546 patients and 618 controls, and 3 on the FASL polymorphism with 321 patients and 307 controls (Fig.…”
Section: Studies Included In the Meta-analysismentioning
confidence: 99%
“…While some studies have found that CTLA-4 rs5742909, CD226 rs763361, FAS-670 rs1800682, and FASL rs763110 polymorphisms are associated with RA, other studies have reported no such association [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31]. To overcome the limitations of individual studies, resolve inconsistencies, and reduce the likelihood that random errors are responsible for false positive or false negative associations [32][33][34], we performed a meta-analysis to determine whether these polymorphisms are associated with RA susceptibility.…”
Section: Introductionmentioning
confidence: 99%
“…This SNP has previously been reported to be associated with type 1 diabetes, MS, and RA in European Caucasian populations [5,7]. Moreover, during preparation of this manuscript, Maiti et al [15] published additional evidence supporting the role of the rs763361 SNP in primary Sjogren's syndrome (pSS), systemic lupus erythematosus, and RA in non-European Caucasians. In our study, we also included this published data for meta-analyses to examine diseasesspecific associations with CD226.…”
Section: Discussionmentioning
confidence: 72%